NCT06014840View on ClinicalTrials.gov

The UCAP 2 Pilot Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
COPDAsthma
Interventions
OTHER

Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD

Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD

Trial Locations (1)

K1H 8L6

Ottawa Hospital General Campus, Ottawa

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Hospital Research Institute

OTHER